drugset / Trial / NCT00139594
Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
NaSingle-groupOpen-labelTreatment
Summary
This extension study is designed to assess the long-tem tolerability and safety of licarbazepine in patients who completed the 6-week double-blind study CLIC477D2303.
Timeline
- Start
- 2004-12
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Licarbazepine | Small molecule | — | — |